Mesirow Financial Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,242
| Closed | -$115K | – | 604 |
|
|
2025
Q1 | $115K | Hold |
10,242
| – | – | ﹤0.01% | 559 |
|
|
2024
Q4 | $135K | Buy |
10,242
+116
| +1% | +$1.53K | ﹤0.01% | 566 |
|
|
2024
Q3 | $195K | Buy |
+10,126
| New | +$195K | ﹤0.01% | 549 |
|
|
2024
Q1 | – | Sell |
-16,024
| Closed | -$358K | – | 594 |
|
|
2023
Q4 | $358K | Buy |
16,024
+3,741
| +30% | +$83.5K | 0.01% | 381 |
|
|
2023
Q3 | $178K | Hold |
12,283
| – | – | 0.78% | 75 |
|
|
2023
Q2 | $257K | Buy |
+12,283
| New | +$257K | 1.09% | 49 |
|
|
2021
Q2 | – | Sell |
-894
| Closed | -$20K | – | 125 |
|
|
2021
Q1 | $20K | Buy |
894
+382
| +75% | +$8.55K | 0.05% | 88 |
|
|
2020
Q4 | $11.4K | Buy |
+512
| New | +$11.4K | 0.04% | 82 |
|